Biohaven Ltd. (BHVN)
9.70
+0.22
(+2.32%)
USD |
NYSE |
May 22, 11:11
Biohaven Shareholders Equity (Quarterly) : 129.50M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics, Inc. | -826.57M |
| Aldeyra Therapeutics, Inc. | 42.16M |
| Biogen, Inc. | 18.65B |
| Ionis Pharmaceuticals, Inc. | 491.41M |
| MediciNova, Inc. | 39.41M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 466.41M |
| Total Liabilities (Quarterly) | 336.91M |
| Debt to Equity Ratio | 2.210 |
| Current Ratio | 7.406 |
| Net Debt Paydown Yield | -3.92% |